Metropolis Healthcare Ltd (METROPOLIS) Q1FY27 Management Mirror - Jun-2026 Qtr
FY27 Revenue Growth Guided at 14%-15%; Q1 FY27 Reported at INR 4,502 Million (+16.6% YoY)
In the Dec'25 Qtr concall, management guided FY26 organic revenue growth of 12% to 13%. In the Mar'26 Qtr concall, organic revenue for FY26 was reported at INR 1,510 crores, registering a 13.7% YoY growth, coming in higher than the previously guided 12% to 13%. Concurrently in the Mar'26 Qtr concall, management initiated guidance for an overall revenue CAGR of 14% to 15% over the next 3 years. In the Jun'26 Qtr concall, management reaffirmed its FY27 revenue growth guidance of 14% to 15%, expecting it to be primarily driven by a targeted 9% to 10% patient volume growth. As reported in the Jun'26 Qtr financial results, Q1 FY27 consolidated revenue stood at INR 4,502 million, reflecting a 16.6% YoY growth (noted as INR 450 crore or ~17% YoY growth in the concall).
5 more themes on the ELITE plan.